Brown Advisory Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,555
| Closed | -$880K | – | 2 |
|
|
2022
Q3 | $880K | Sell |
6,555
-12,807
| -66% | -$1.84M | 3.22% | 7 |
|
|
2022
Q2 | $2.97M | Sell |
19,362
-5,334
| -22% | -$815K | 2.8% | 5 |
|
|
2022
Q1 | $4M | Sell |
24,696
-12,718
| -34% | -$1.85M | 2.34% | 5 |
|
|
2021
Q4 | $5.07M | Sell |
37,414
-17,126
| -31% | -$2.02M | 2.16% | 5 |
|
|
2021
Q3 | $5.89M | Sell |
54,540
-20,948
| -28% | -$2.39M | 1.74% | 11 |
|
|
2021
Q2 | $8.5M | Sell |
75,488
-2,213
| -3% | -$249K | 1.33% | 18 |
|
|
2021
Q1 | $8.41M | Buy |
77,701
+1,919
| +3% | +$205K | 1.43% | 17 |
|
|
2020
Q4 | $8.12M | Buy |
75,782
+19,735
| +35% | +$1.9M | 1.39% | 15 |
|
|
2020
Q3 | $4.91M | Buy |
56,047
+8,154
| +17% | +$768K | 1% | 23 |
|
|
2020
Q2 | $4.73M | Buy |
47,893
+3,355
| +8% | +$295K | 1.01% | 23 |
|
|
2020
Q1 | $3.37M | Buy |
44,538
+7,301
| +20% | +$622K | 0.86% | 28 |
|
|
2019
Q4 | $3.3M | Sell |
37,237
-3,331
| -8% | -$277K | 0.79% | 33 |
|
|
2019
Q3 | $3.07M | Buy |
40,568
+310
| +0.8% | +$21.3K | 0.86% | 30 |
|
|
2019
Q2 | $2.92M | Buy |
40,258
+2,085
| +5% | +$164K | 0.78% | 32 |
|
|
2019
Q1 | $3.07M | Sell |
38,173
-5,381
| -12% | -$440K | 0.72% | 36 |
|
|
2018
Q4 | $3.89M | Sell |
43,554
-393
| -0.9% | -$34.6K | 0.74% | 35 |
|
|
2018
Q3 | $4.15M | Sell |
43,947
-3,509
| -7% | -$333K | 0.67% | 37 |
|
|
2018
Q2 | $4.4M | Sell |
47,456
-299
| -0.6% | -$29.2K | 0.76% | 29 |
|
|
2018
Q1 | $4.52M | Buy |
47,755
+206
| +0.4% | +$22.6K | 0.84% | 28 |
|
|
2017
Q4 | $4.6M | Sell |
47,549
-317
| -0.7% | -$29.9K | 0.89% | 25 |
|
|
2017
Q3 | $4.26M | Buy |
47,866
+880
| +2% | +$67K | 0.92% | 24 |
|
|
2017
Q2 | $3.42M | Buy |
46,986
+244
| +0.5% | +$16.4K | 0.78% | 32 |
|
|
2017
Q1 | $3.05M | Buy |
46,742
+1,512
| +3% | +$95.1K | 0.76% | 35 |
|
|
2016
Q4 | $2.83M | Buy |
45,230
+2,267
| +5% | +$138K | 0.77% | 36 |
|
|
2016
Q3 | $2.71M | Buy |
42,963
+806
| +2% | +$52.2K | 0.79% | 32 |
|
|
2016
Q2 | $2.61M | Buy |
42,157
+838
| +2% | +$51.1K | 0.81% | 33 |
|
|
2016
Q1 | $2.36M | Buy |
41,319
+402
| +1% | +$22.4K | 0.77% | 36 |
|
|
2015
Q4 | $2.43M | Sell |
40,917
-3,948
| -9% | -$227K | 0.83% | 33 |
|
|
2015
Q3 | $2.44M | Buy |
44,865
+813
| +2% | +$52.9K | 0.88% | 31 |
|
|
2015
Q2 | $2.96M | Sell |
44,052
-116
| -0.3% | -$7.57K | 0.99% | 23 |
|
|
2015
Q1 | $2.59M | Buy |
44,168
+5,821
| +15% | +$352K | 0.89% | 26 |
|
|
2014
Q4 | $2.51M | Sell |
38,347
-484
| -1% | -$30.5K | 0.91% | 25 |
|
|
2014
Q3 | $2.25M | Buy |
38,831
+1,214
| +3% | +$67.4K | 0.83% | 29 |
|
|
2014
Q2 | $2.13M | Buy |
37,617
+3,314
| +10% | +$174K | 0.77% | 32 |
|
|
2014
Q1 | $1.76M | Buy |
34,303
+2,642
| +8% | +$134K | 0.69% | 38 |
|
|
2013
Q4 | $1.67M | Sell |
31,661
-1,665
| -5% | -$81.8K | 0.67% | 39 |
|
|
2013
Q3 | $1.49M | Buy |
33,326
+694
| +2% | +$30.8K | 0.65% | 39 |
|
|
2013
Q2 | $1.34M | Buy |
+32,632
| New | +$1.43M | 0.65% | 39 |
|
Other funds holding ABBV
AWA
Brown Advisory Securities's ABBV Position: Q4 2022 in Review
Brown Advisory Securities sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 6,555 shares — an estimated $880K sold.
Brown Advisory Securities first reported a position in ABBV in Q2 2013 and held it in 38 quarters. The position peaked at $8.5M in Q2 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.
- Brown Advisory Securities reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
- Brown Advisory Securities sold 6,555 AbbVie shares in Q4 2022, an estimated $880K.
- Brown Advisory Securities first reported a position in AbbVie in Q2 2013 and held it in 38 quarters.
- Brown Advisory Securities's AbbVie position peaked at $8.5M in Q2 2021.
- 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.
Based on Brown Advisory Securities's 13F filing for Q4 2022.